ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 49 filers reported holding ALLENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $643,000 | -74.3% | 667,800 | -27.2% | 0.08% | -61.4% |
Q4 2019 | $2,506,000 | -5.6% | 917,800 | +36.2% | 0.21% | -49.5% |
Q3 2019 | $2,655,000 | +32.8% | 673,881 | +37.2% | 0.41% | +50.2% |
Q2 2019 | $1,999,000 | -34.0% | 491,193 | +13.9% | 0.27% | -1.1% |
Q1 2019 | $3,027,000 | +60.9% | 431,193 | +24.9% | 0.28% | +30.2% |
Q4 2018 | $1,881,000 | -40.7% | 345,199 | +16.9% | 0.21% | -41.8% |
Q3 2018 | $3,170,000 | -9.0% | 295,199 | +10.4% | 0.36% | -24.2% |
Q2 2018 | $3,484,000 | -22.9% | 267,349 | -34.8% | 0.48% | -30.0% |
Q1 2018 | $4,520,000 | +38.2% | 410,199 | +26.2% | 0.69% | +78.6% |
Q4 2017 | $3,270,000 | – | 325,000 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,790,964 | $2,518,000 | 11.16% |
AIGH Capital Management LLC | 4,000,000 | $3,608,000 | 0.76% |
Worth Venture Partners, LLC | 980,200 | $884,000 | 0.40% |
Altium Capital Management LP | 1,067,886 | $963,000 | 0.25% |
FRAZIER MANAGEMENT LLC | 3,330,373 | $3,005,000 | 0.24% |
Golden Green, Inc. | 33,000 | $30,000 | 0.02% |
LEVEL FOUR FINANCIAL, LLC | 40,000 | $36,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 152,731 | $138,000 | 0.01% |
PFM Health Sciences, LP | 284,285 | $256,000 | 0.01% |
XTX Topco Ltd | 21,443 | $19,000 | 0.01% |